ResMed Inc.RMDNYSE
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank77
3Y CAGR-9.4%
5Y CAGR+0.4%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-9.4%/yr
Quarterly compound
5Y CAGR
+0.4%/yr
Recent deceleration
Percentile
P77
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 6.53% |
| Q3 2025 | -0.92% |
| Q2 2025 | 4.36% |
| Q1 2025 | 0.75% |
| Q4 2024 | 4.70% |
| Q3 2024 | 0.11% |
| Q2 2024 | 2.19% |
| Q1 2024 | 2.94% |
| Q4 2023 | 5.49% |
| Q3 2023 | -1.76% |
| Q2 2023 | 0.46% |
| Q1 2023 | 8.04% |
| Q4 2022 | 8.78% |
| Q3 2022 | 3.89% |
| Q2 2022 | 5.81% |
| Q1 2022 | -3.39% |
| Q4 2021 | -1.01% |
| Q3 2021 | 3.19% |
| Q2 2021 | 13.96% |
| Q1 2021 | -3.91% |
| Q4 2020 | 6.39% |
| Q3 2020 | -2.39% |
| Q2 2020 | 0.12% |
| Q1 2020 | 4.52% |
| Q4 2019 | 8.09% |
| Q3 2019 | -3.39% |
| Q2 2019 | 6.45% |
| Q1 2019 | 1.71% |
| Q4 2018 | 10.68% |
| Q3 2018 | -5.67% |
| Q2 2018 | 5.41% |
| Q1 2018 | -1.60% |
| Q4 2017 | 14.82% |
| Q3 2017 | -5.93% |
| Q2 2017 | 8.26% |
| Q1 2017 | -3.05% |
| Q4 2016 | 13.95% |
| Q3 2016 | -10.26% |
| Q2 2016 | 14.27% |
| Q1 2016 | -0.15% |